Viking Therapeutics Inc (NASDAQ: VKTX) kicked off on Tuesday, up 1.49% from the previous trading day, before settling in for the closing price of $66.95. Over the past 52 weeks, VKTX has traded in a range of $8.28-$99.41.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded -23.49%. With a float of $100.41 million, this company’s outstanding shares have now reached $109.36 million.
In an organization with 27 employees, it is important to assess its efficiency.
Viking Therapeutics Inc (VKTX) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Viking Therapeutics Inc is 8.18%, while institutional ownership is 69.83%. The most recent insider transaction that took place on Feb 09 ’24, was worth 1,345,500. In this transaction President & CEO of this company sold 45,000 shares at a rate of $29.90, taking the stock ownership to the 2,139,882 shares. Before that another transaction happened on Feb 08 ’24, when Company’s President & CEO sold 269,079 for $26.87, making the entire transaction worth $7,230,784. This insider now owns 2,184,882 shares in total.
Viking Therapeutics Inc (VKTX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -23.49% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.00% during the next five years compared to -18.89% drop over the previous five years of trading.
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
Take a look at Viking Therapeutics Inc’s (VKTX) current performance indicators. Last quarter, stock had a quick ratio of 19.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.91, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -1.52 in one year’s time.
Technical Analysis of Viking Therapeutics Inc (VKTX)
Let’s dig in a bit further. During the last 5-days, its volume was 2.36 million. That was inferior than the volume of 5.93 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 8.06%. Additionally, its Average True Range was 5.47.
During the past 100 days, Viking Therapeutics Inc’s (VKTX) raw stochastic average was set at 64.33%, which indicates a significant increase from 12.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.18% in the past 14 days, which was lower than the 157.01% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $62.03, while its 200-day Moving Average is $26.68. However, in the short run, Viking Therapeutics Inc’s stock first resistance to watch stands at $69.12. Second resistance stands at $70.29. The third major resistance level sits at $72.10. If the price goes on to break the first support level at $66.14, it is likely to go to the next support level at $64.33. Assuming the price breaks the second support level, the third support level stands at $63.16.
Viking Therapeutics Inc (NASDAQ: VKTX) Key Stats
The company with the Market Capitalisation of 7.43 billion has total of 110,218K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -85,900 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -24,600 K.
